By Dr. Arturo Mendoza-Valdés Under the joint leadership of Dr. Ashish Kamat, President of the International Bladder Cancer Group (IBCG), and Dr. Arturo Mendoza-Valdés, member of the IBCG and Scientific Committee Chairman of the Mexican Urologic Oncology Association (AMUO), and its former and current Presidents, Dr. Juan Carlos Huerta and Dr. Héctor Sanchez, respectively, a landmark initiative was launched to develop the Mexican Bladder Cancer Guidelines. Following almost two years of dedicated work, the IBCG, together with the AMUO, the Mexican Urologic Association (SMU), and the Colegio Mexicano de Urología (CMUN), convened on October 3–4, 2024 in Mexico City to create the first national, evidence-based guidelines for the diagnosis and management of bladder cancer in Mexico. While numerous international guidelines exist—such as those of the AUA, EAU, NCCN, and IBCG—most are broadly concordant, differing mainly in nuance. The goal of this project was not to reinvent new guidelines, but rather to integrate the best elements of existing ones, updated with the latest evidence, into a clear, practical, and resource-sensitive framework reflecting Mexico’s healthcare systems. To ensure genuine national representation and broad consensus, the Presidents of the major Mexican urologic associations and leading urologists dedicated to bladder cancer were invited to […]